Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“It was truly an honor to be hosted in Riyadh as a speaker—an enriching visit filled with insightful discussions, collaboration, and shared passion for advancing multiple myeloma care.
I had the privilege of connecting with exceptional colleagues and leaders from the Saudi Myeloma Group, whose dedication, innovation, and growing infrastructure are truly impressive. The energy and commitment to improving patient outcomes are inspiring.
Moments like these reinforce the importance of global collaboration in hematologic malignancies. I am excited about the opportunities ahead and look forward to building meaningful partnerships-hopefully leading to joint research initiatives, clinical trials, and continued knowledge exchange.
Grateful for the warm hospitality and looking forward to what we can achieve together.”
Other articles about Multiple Myeloma on OncoDaily.
